REFERENCES

1. Revised National Tuberculosis Control Programme. Technical guidelines for TB control. Central TB Division, Directorate General of Health Services. New Delhi, India: Nirman Bhavan, 1997.
2. Studies on the treatment of tuberculosis. British Medical Research Council Tuberculosis Unit 1946–1986. Int J Tuberc Lung Dis 1999; 3 (Suppl 2): 10.
3. Central TB Division. TB India 2004: RNTCP Status Report. New Delhi, India: Directorate General of Health Services, Government of India, 2004. www.tbcindia.org Accessed March 2005.
4. World Health Organization. Treatment of Tuberculosis Guidelines. 4th ed. World Health Organization; 2010. Available from: http:// www.whqlibdoc.who.int/publications/2010/9789241547833_eng. pdf. [Last accessed on 2014 May 17].
5. World Health Organization. Fact Sheet No. 104: Tuberculosis. Geneva: WHO; 2010. Available from: http://www.who.int/ mediacentre/factsheets/fs104/en/print.html. [Last accessed on 2014 May 16].
6. Tuberculosis Research Centre. Study of chemotherapy regimens of 5 and 7 months duration and the role of corticosteroids in the treatment of sputum positive patients with pulmonary tuberculosis in south India. Tubercle 1983; 64: 73–91.
7. Tuberculosis Research Centre. A controlled clinical trial of oral short course regimens in the treatment of sputum positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 16: 509–517.
8. Mitchison D A, Nunn A J. Influence of initial drug resistance on the response to treatment of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 423–430.
9. Tuberculosis Research Centre. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy. Int J Tuberc Lung Dis 2001; 5: 40–45.
10. Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8: 17–21.
11. Frieden T R, Mostashari F, Kerker B D, Miller N, Hajat A, Frankel M. Rapid decline in adult tobacco use following intensive tobacco control measures, New York City 2002–2003. Am J Public Health 2005 (in press)
12. Second East African/British Medical Research Council Study. Controlled clinical trial of four 6 month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1976; 114: 471–475.
13. Abinash Agarwala, Kaushik Saha, Shelley Shamim, Partha Pratim Roy. The profile and treatment outcomes of sputum smearpositive pulmonary tuberculosis re‑treatment cases, in a district medical college of West Bengal, India. The Journal of Association of Chest Physicians. Jul‑Dec 2014; 2 (2): 63-67.